港龍中國地產(06968.HK)與合營企業夥伴置換兩個項目權益
港龍中國地產(06968.HK)宣布與合營企業夥伴訂立股權置換協議,旗下安徽港龍將獲合營企業夥伴轉轉讓其持有的黃山項目公司30%股權,代價為1.5217億元人民幣,而另一附屬安徽港帆將向合營企業夥伴轉讓其持有的廣德項目公司全部股權,代價同為1.5217億元人民幣,兩者將抵銷。
完成置換後,黃山項目公司將由集團全資持有,該公司主要持有位於安徽省黃山市屯溪區屯光鎮北海路北側的黃山地盤全部權益。該地盤面積約為46,780平方米,可出售總建築面積為71,866平方米,住宅項目「港龍君望」目前正在開發中,建築工程預期將於2023年3月竣工,項目並已取得商品房預售許可證,截至去年底可出售總建築面積10,471平方米經已預售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.